« Back to Medicines list

ACARIZAX 12 SQ-HDM oral lyophilisate

  • Name:

    ACARIZAX 12 SQ-HDM oral lyophilisate

  • Company:
    info
  • Active Ingredients:

    Allergen extract from house dust mites

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 27/07/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 27/7/2020
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Click on this link to Download PDF directly

ALK-Abello Ltd

ALK-Abello Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name ACARIZAX 12 SQ-HDM oral lyophilisate Active Ingredients Allergen extract from house dust mites
Medicine Name ALUTARD SQ Bee 100,000 SQ-U/ml Active Ingredients Allergen from honey bee venom
Medicine Name ALUTARD SQ Bee Initial pack (100 SQ-U/ml, 1,000 SQ-U/ml, 10,000 SQ-U/ml, 100,000 SQ-U/ml) Active Ingredients Allergen from honey bee venom
Medicine Name ALUTARD SQ Wasp 100,000 SQ-U/ml Active Ingredients Allergen from wasp venom
Medicine Name ALUTARD SQ Wasp Initial Pack (100 SQ-U/ml, 1,000 SQ-U/ml, 10,000 SQ-U/ml, 100,000 SQ-U/ml) Active Ingredients Allergen from wasp venom
Medicine Name GRAZAX 75,000 SQ-T oral lyophilisate Active Ingredients allergen extract of grass pollen from Timothy (Phleum pratense)
Medicine Name ITULAZAX 12 SQ-Bet oral lyophilisate Active Ingredients Allergen extract of pollen from white birch
Medicine Name Jext 150mcg Active Ingredients Adrenaline tartrate
Medicine Name Jext 300mcg Active Ingredients Adrenaline tartrate
1 - 0 of 9 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 27 July 2020

Reasons for updating

  • Change to section 9 - Date of first authorisation/renewal of the authorisation

Free text change information supplied by the pharmaceutical company

Minor wording changes submitted as part of renewal

Updated on 27 July 2020 PIL

Reasons for updating

  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

Minor wording changes submitted as part of the renewal

Updated on 16 June 2020

Reasons for updating

  • New SmPC for medicines.ie

Updated on 16 June 2020

Reasons for updating

  • New SmPC for new product

Updated on 16 June 2020 PIL

Reasons for updating

  • New PIL for new product